Bis(2-ethylhexyl) hydrogen phosphate
Common Name: |
Bis(2-ethylhexyl) hydrogen phosphate |
IUPAC Name: |
bis(2-ethylhexyl) hydrogen phosphate |
Molecular Formula: |
C16H35O4P |
SMILES: |
CCCCC(CC)COP(=O)(O)OCC(CC)CCCC |
Inchi: |
1S/C16H35O4P/c1-5-9-11-15(7-3)13-19-21(17,18)20-14-16(8-4)12-10-6-2/h15-16H,5-14H2,1-4H3,(H,17,18) |
Inchi Key: |
SEGLCEQVOFDUPX-UHFFFAOYSA-N |
Cas No: |
298-07-7 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
1 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
322.42 |
Mass (g/mol) |
322.227 |
Molar Refractivity |
91.02 |
Net Charge |
-1 |
HBD |
1 |
HBA |
4 |
Rt Bonds |
14 |
Rings |
|
TPSA |
65.57 |
Hetero Atoms |
5 |
Heavy Atoms |
21 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
-50 |
Boiling Point (°C@760.00mm Hg) |
155 at 0.015 mm Hg |
Vapor Pressure (mmHg@25.00 °C) |
|
Vapor Density (Air =1) |
|
Fraction Csp3 |
1.00 |
LogP |
5.553 |
iLOGP |
3.77 |
XLOGP3 |
5.24 |
WLOGP |
5.55 |
MLOGP |
3.27 |
ESOL Log S |
-4.22 |
ESOL Solubility (mg/ml) |
0.02 |
ESOL Solubility (mol/l) |
0 |
ESOL Class: esol_class |
Moderately soluble |
Ali Log S |
-6.37 |
Ali Solubility (mg/ml) |
0 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Poorly soluble |
Silicos-IT LogSw |
-4.47 |
Silicos-IT Solubility (mg/ml) |
0.01 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Moderately soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
0 |
PgP Substrate |
1 |
Log Kp (cm/s) |
-4.55 |
Bioavailability Score |
0.85 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.984 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
1 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
1 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
2.255 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
1 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
1 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
1 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |